Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001178913-23-000694
Filing Date
2023-02-22
Accepted
2023-02-22 06:03:49
Documents
75

Document Format Files

Seq Description Document Type Size
1 S-1/A zk2329281.htm   iXBRL S-1/A 1666104
2 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 3377
8 GRAPHIC cmmb_img01.jpg GRAPHIC 2815
9 GRAPHIC cmmb_img02.jpg GRAPHIC 5150
10 GRAPHIC image00003.jpg GRAPHIC 5150
  Complete submission text file 0001178913-23-000694.txt   5861441

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cmmb-20221231.xsd EX-101.SCH 56413
4 XBRL CALCULATION FILE cmmb-20221231_cal.xml EX-101.CAL 46539
5 XBRL DEFINITION FILE cmmb-20221231_def.xml EX-101.DEF 128511
6 XBRL LABEL FILE cmmb-20221231_lab.xml EX-101.LAB 489385
7 XBRL PRESENTATION FILE cmmb-20221231_pre.xml EX-101.PRE 263879
69 EXTRACTED XBRL INSTANCE DOCUMENT zk2329281_htm.xml XML 703613
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-269218 | Film No.: 23650430
SIC: 2834 Pharmaceutical Preparations